Molecular pathology of pancreatic cancer.

Abstract excerpt

By genomic and epigenomic screening techniques, substantial progress has been made in our understanding of pancreatic cancer. The comprehensive studies of the pancreatic cancer genome have revealed that most genetic alterations are identified to be associated with specific core signaling pathways including high-frequency mutated genes such as KRAS, CDKN2A, TP53, and SMAD4 along with several low-frequency mutated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Progression
• Share to Gene Expression Regulation, Neoplastic
• Share to KRAS gene